1363382-02-8 Usage
Uses
Used in Organic Synthesis:
4-Bromo-3-methyl-7-azaindole is used as a building block in organic synthesis for the preparation of various biologically active molecules and pharmaceuticals. Its unique structure with a bromine and methyl group allows for the creation of diverse chemical compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-bromo-3-methyl-7-azaindole serves as a key intermediate for the development of new drugs. Its structural features make it a promising candidate for the synthesis of therapeutic agents with potential applications in various medical fields.
Used in Antimicrobial Applications:
4-Bromo-3-methyl-7-azaindole has been studied for its potential antimicrobial properties, making it a candidate for the development of new antimicrobial agents to combat resistant bacteria and other microorganisms.
Used in Antiviral Applications:
4-BroMo-3-Methyl-7-azaindole has also been investigated for its potential antiviral properties, indicating its potential use in the development of antiviral drugs to treat various viral infections.
Used in Anticancer Applications:
4-Bromo-3-methyl-7-azaindole has been studied for its potential anticancer properties, suggesting its use in the development of new anticancer drugs. Its derivatives have been investigated for their potential as therapeutic agents in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1363382-02-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,3,3,8 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1363382-02:
(9*1)+(8*3)+(7*6)+(6*3)+(5*3)+(4*8)+(3*2)+(2*0)+(1*2)=148
148 % 10 = 8
So 1363382-02-8 is a valid CAS Registry Number.
1363382-02-8Relevant academic research and scientific papers
MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 72-73, (2018/03/25)
The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
